ICA Group Wealth Management’s Pacira BioSciences PCRX Stock Holding History

ICA Group Wealth Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$25.7K	Hold	900	–	–	0.02%	324
2024 Q1	$26.3K	Hold	900	–	–	0.01%	694
2023 Q4	$30.4K	Buy	+900	New	+$26.3K	0.01%	619
2023 Q3	–	Sell	-900	Closed	-$36.1K	–	920
2023 Q2	$36.1K	Hold	900	–	–	0.01%	563
2023 Q1	$36.7K	Hold	900	–	–	0.01%	542
2022 Q4	$35.3K	Buy	+900	New	+$43.8K	0.01%	585

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ICA Group Wealth Management's PCRX Position: Q2 2024 in Review

ICA Group Wealth Management held its Pacira BioSciences (PCRX) position steady in Q2 2024 at 900 shares worth $25.7K. The position accounts for 0.02% of the portfolio, ranked #324.

ICA Group Wealth Management first reported a position in PCRX in Q4 2022 and has held it in 6 quarters since. The position peaked at $36.7K in Q1 2023. 280 funds tracked by Wall St. Rank hold PCRX as of Q2 2024.

ICA Group Wealth Management held 900 shares of Pacira BioSciences worth $25.7K as of Q2 2024.
ICA Group Wealth Management left its Pacira BioSciences share count unchanged in Q2 2024.
Pacira BioSciences made up 0.02% of ICA Group Wealth Management's portfolio in Q2 2024, its #324 holding.
ICA Group Wealth Management first reported a position in Pacira BioSciences in Q4 2022 and has held it in 6 quarters since.
ICA Group Wealth Management's Pacira BioSciences position peaked at $36.7K in Q1 2023.
280 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.